A matched-control comparison of serious adverse events after intravitreal injections of bevacizumab for age-related macular degeneration and cataract extraction

PURPOSE: The study reported here investigated the rates of systemic serious adverse events (SAEs) following treatment with intravitreal bevacizumab for age-related macular degeneration (AMD) in comparison with a matched control group. METHODS: A retrospective age- and sex-matched case-control design...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Naomi, Moisseiev, Elad, Waisbourd, Michael, Goldstein, Michaella, Loewenstein, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615876/
https://www.ncbi.nlm.nih.gov/pubmed/23569355
http://dx.doi.org/10.2147/OPTH.S42881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615876/
https://www.ncbi.nlm.nih.gov/pubmed/23569355
http://dx.doi.org/10.2147/OPTH.S42881

Ejemplares similares